Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates

mBio

Volumn 3, Issue 5, 2012, Pages

  Marinelli, Laura J ^a   Fitz Gibbon, Sorel ^b   Hayes, Clarmyra ^a,f   Bowman, Charles ^c   Inkeles, Megan ^b   Loncaric, Anya ^a,e   Russell, Daniel A ^c   Jacobs Sera, Deborah ^c   Cokus, Shawn ^b   Pellegrini, Matteo ^b   Kim, Jenny ^a,d   Miller, Jeff F ^a   Hatfull, Graham F ^c   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e Solta Medical Inc   (United States)

^f CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868378578     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00279-12     Document Type: Article

References (52)

1. Casjens SR. 2008. Diversity among the tailed-bacteriophages that infect the Enterobacteriaceae. Res. Microbiol. 159:340-348.
2. Hatfull GF, Science Education Alliance Phage Hunters Advancing Genomics and Evolutionary Science Program, KwaZulu-Natal Research Institute for Tuberculosis and HIV Mycobacterial Genetics Course Students, Phage Hunters Integrating Research and Education Program. 2012. Complete genome sequences of 138 mycobacteriophages. J. Virol. 86:2382-2384.
3. Hatfull GF, et al. 2010. Comparative genomic analysis of sixty mycobac-teriophage genomes: genome clustering, gene acquisition, and gene size. J. Mol. Biol. 397:119-143.
4. Pope WH, et al. 2011. Cluster K mycobacteriophages: insights into the evolutionary origins of mycobacteriophage TM4. PLoS One 6:e26750.
5. Pope WH, et al. 2011. Expanding the diversity of mycobacteriophages: insights into genome architecture and evolution. PLoS One 6:e16329.
6. Goerke C, et al. 2009. Diversity of prophages in dominant Staphylococcus aureus clonal lineages. J. Bacteriol. 191:3462-3468.
7. Kwan T, Liu J, Dubow M, Gros P, Pelletier J. 2005. The complete genomes and proteomes of27 Staphylococcus aureusbacteriophages. Proc. Natl. Acad. Sci. U. S. A. 102:5174-5179.
8. Ceyssens PJ, Lavigne R. 2010. Bacteriophages of Pseudomonas. Future Microbiol. 5:1041-1055.
9. Kwan T, Liu J, Dubow M, Gros P, Pelletier J. 2006. Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J. Bacte-riol. 188:1184-1187.
10. Bek-Thomsen M, Lomholt HB, Kilian M. 2008. Acne is not associated with yet-uncultured bacteria. J. Clin. Microbiol. 46:3355-3360.
11. Kim J, et al. 2002. Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169:1535-1541.
12. Leyden JJ, McGinley KJ, Mills OH, Kligman AM. 1975. Propionibacte-rium levels in patients with and without acne vulgaris. J. Invest. Dermatol. 65:382-384.
13. Eady EA, Cove JH, Holland KT, Cunliffe WJ. 1989. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br. J. Dermatol. 121:51-57.
14. Coates P, et al. 2002. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br. J. Dermatol. 146:840-848.
15. Cooper AJ. 1998. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med. J. Aust. 169:259-261.
16. Ross JI, et al. 2003. Antibiotic-resistant acne: lessons from Europe. Br. J. Dermatol. 148:467-478.
17. Jong EC, Ko HL, Pulverer G. 1975. Studies on bacteriophages of Propi-onibacterium acnes. Med. Microbiol. Immunol. 161:263-271.
18. Webster GF, Cummins CS. 1978. Use of bacteriophage typing to distinguish Propionibacterium acne types I and II. J. Clin. Microbiol. 7:84-90.
19. Zierdt CH, Webster C, Rude WS. 1968. Study of the anaerobic coryne-bacteria. Int. J. Syst. Bacteriol. 18:33- 47.
20. Farrar MD, et al. 2007. Genome sequence and analysis of a Propionibac-terium acnes bacteriophage. J. Bacteriol. 189:4161-4167.
21. Lood R, Collin M. 2011. Characterization and genome sequencing of two Propionibacterium acnes phages displaying pseudolysogeny. BMC Genomics 12:198.
22. Lood R, Mörgelin M, Holmberg A, Rasmussen M, Collin M. 2008. Inducible Siphoviruses in superficial and deep tissue isolates of Propi-onibacterium acnes. BMC Microbiol. 8:139.
23. Zierdt CH. 1974. Properties of Corynebacterium acnes bacteriophage and description of an interference phenomenon. J. Virol. 14:1268-1273.
24. Lawrence JG, Ochman H. 1997. Amelioration of bacterial genomes: rates of change and exchange. J. Mol. Evol. 44:383-397.
25. Loessner MJ. 2005. Bacteriophage endolysins-current state of research and applications. Curr. Opin. Microbiol. 8:480-487.
26. Payne KM, Hatfull GF. 2012. Mycobacteriophage endolysins: diverse and modular enzymes with multiple catalytic activities. PLoS One 7:e34052.
27. McDowell A, et al. 2005. Propionibacterium acnes types I and II represent phylogenetically distinct groups. J. Clin. Microbiol. 43:326-334.
28. Labrie SJ, Samson JE, Moineau S. 2010. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8:317-327.
29. Brüggemann H, Lomholt HB, Tettelin H, Kilian M. 2012. CRISPR/cas loci of type II Propionibacterium acnes confer immunity against acquisition of mobile elements present in type I P. acnes. PLoS One 7:e34171.
30. Makarova KS, Aravind L, Wolf YI, Koonin EV. 2011. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct 6:38.
31. Makarova KS, et al. 2011. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9:467-477.
32. Pride DT, et al. 2012. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 6:915-926.
33. Gill SR, et al. 2006. Metagenomic analysis of the human distal gut micro-biome. Science 312:1355-1359.
34. Housby JN, Mann NH. 2009. Phage therapy. Drug Discov. Today 14: 536-540.
35. Marza JA, Soothill JS, Boydell P, Collyns TA. 2006. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns 32:644-646.
36. Ochs HD, Davis SD, Wedgwood RJ. 1971. Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J. Clin. Invest. 50:2559-2568.
37. Dubos RJ, Straus JH, Pierce C. 1943. The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae. J. Exp. Med. 78:161-168.
38. Capparelli R, Ventimiglia I, Roperto S, Fenizia D, Iannelli D. 2006. Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin. Microbiol. Infect. 12:248-253.
39. Smith HW, Huggins MB. 1982. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318.
40. Matsuzaki S, et al. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J. Infect. Dis. 187:613-624.
41. Wills QF, Kerrigan C, Soothill JS. 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. An-timicrob. Agents Chemother. 49:1220-1221.
42. Fischetti VA. 2008. Bacteriophage lysins as effective antibacterials. Curr. Opin. Microbiol. 11:393-400.
43. Gao Z, Perez-Perez GI, Chen Y, Blaser MJ. 2010. Quantitation of major human cutaneous bacterial and fungal populations. J. Clin. Microbiol. 48:3575-3581.
44. Grice EA, et al. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324:1190-1192.
45. Lowe TM, Eddy SR. 1997. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25: 955-964.
46. Laslett D, Canback B. 2004. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res. 32:11-16.
47. Xu J, Hendrix RW, Duda RL. 2004. Conserved translational frameshift in dsDNA bacteriophage tail assembly genes. Mol. Cell 16:11-21.
48. Krumsiek J, Arnold R, Rattei T. 2007. Gepard: a rapid and sensitive tool for creating dotplots on genome scale. Bioinformatics 23:1026-1028.
49. Cresawn SG, et al. 2011. Phamerator: a bioinformatic tool for comparative bacteriophage genomics. BMC Bioinformatics 12:395.
50. LiPuma JJ, et al. 1999. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J. Clin. Microbiol. 37:3167-3170.
51. Huson DH. 1998. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics 14:68-73.
52. Kearse M, et al. 2012. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647-1649.